A novel approach for quantitation of glucosylceramide in human dried blood spot using LC-MS/MS

被引:10
作者
Ji, Allena Ji [1 ]
Wang, Haixing [1 ]
Ziso-Qejvanaj, Enida [1 ]
Zheng, Kefei [1 ]
Chung, Lee Lee [1 ]
Foley, Timothy [1 ]
Chuang, Wei-Lien [2 ]
Richards, Susan [1 ]
Sung, Crystal [1 ]
机构
[1] Sanofi, Clin Specialty Lab, DSAR, Framingham, MA 01701 USA
[2] Sanofi, Biol Mass Spectrometry & Biomarker Res, Framingham, MA 01701 USA
关键词
GAUCHER-DISEASE; BIOANALYTICAL METHODS; CERAMIDE TRIHEXOSIDE; HUMAN PLASMA; ASSAY BIAS; SPHINGOLIPIDS; HEMATOCRIT; QUANTIFICATION; IMPLEMENTATION; SPHINGOMYELIN;
D O I
10.4155/bio.15.77
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Glucosylceramide, an efficacy biomarker for Gaucher Type 1 disease, exhibits poor solubility in polar solvents and whole blood which makes it difficult to prepare a homogenous blood standard. Results: We developed a novel method using standard addition approach by spiking a small volume of analyte solution on the surface of prespotted dried blood spot. The whole spots were punched out for subsequent extraction and LC-MS/MS analysis. The assay performance met all validation acceptance criteria. Glucosylceramide concentrations in 50 paired plasma and dry blood spot samples obtained from Gaucher Type 1 patients were tested and the results demonstrated the feasibility of using the DBS method for clinical biomarker monitoring. Conclusion: The new approach greatly improves assay precision and accuracy.
引用
收藏
页码:1483 / 1496
页数:14
相关论文
共 27 条
[1]  
Adam BW, 2000, CLIN CHEM, V46, P126
[2]   Workshop Report: Crystal City V-Quantitative Bioanalytical Method Validation and Implementation: The 2013 Revised FDA Guidance [J].
Booth, Brian ;
Arnold, Mark E. ;
DeSilva, Binodh ;
Amaravadi, Lakshmi ;
Dudal, Sherri ;
Fluhler, Eric ;
Gorovits, Boris ;
Haidar, Sam H. ;
Kadavil, John ;
Lowes, Steve ;
Nicholson, Robert ;
Rock, Marie ;
Skelly, Michael ;
Stevenson, Lauren ;
Subramaniam, Sriram ;
Weiner, Russell ;
Woolf, Eric .
AAPS JOURNAL, 2015, 17 (02) :277-288
[3]   Analysis of sphingolipids in extracted human plasma using liquid chromatography electrospray ionization tandem mass spectrometry [J].
Bui, Hai H. ;
Leohr, Jennifer K. ;
Kuo, Ming-Shang .
ANALYTICAL BIOCHEMISTRY, 2012, 423 (02) :187-194
[4]   An Introduction to Sphingolipid Metabolism and Analysis by New Technologies [J].
Chen, Yanfeng ;
Liu, Ying ;
Sullards, M. Cameron ;
Merrill, Alfred H., Jr. .
NEUROMOLECULAR MEDICINE, 2010, 12 (04) :306-319
[5]   Lyso-sphingomyelin is elevated in dried blood spots of Niemann-Pick B patients [J].
Chuang, Wei-Lien ;
Pacheco, Joshua ;
Cooper, Samantha ;
McGovern, Margaret M. ;
Cox, Gerald F. ;
Keutzer, Joan ;
Zhang, X. Kate .
MOLECULAR GENETICS AND METABOLISM, 2014, 111 (02) :209-211
[6]   The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs [J].
Denniff, Philip ;
Spooner, Neil .
BIOANALYSIS, 2010, 2 (08) :1385-1395
[7]  
Fauci AS, 2008, HARRISONSS PRINCIPLE
[8]   Quantification of glucosylceramide in plasma of Gaucher disease patients [J].
Gomes Muller, Maria Viviane ;
Petry, Andre ;
Vianna, Luciene Pinheiro ;
Breier, Ana Carolina ;
Michelin-Tirelli, Kristiane ;
Pires, Ricardo Flores ;
Treis Trindade, Vera Maria ;
Coelho, Janice Carneiro .
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 46 (04) :643-649
[9]   HPLC for simultaneous quantification of total ceramide, glucosylceramide, and ceramide trihexoside concentrations in plasma [J].
Groener, Johanna E. M. ;
Poorthuis, Ben J. H. M. ;
Kuiper, Sijmen ;
Helmond, Mariette T. J. ;
Hollak, Carla E. M. ;
Aerts, Johannes M. F. G. .
CLINICAL CHEMISTRY, 2007, 53 (04) :742-747
[10]   An Improved Method for Analysis of Glucosylceramide Species Having cis-8 and trans-8 Isomers of Sphingoid Bases by LC-MS/MS [J].
Imai, Hiroyuki ;
Hattori, Hideyasu ;
Watanabe, Masayuki .
LIPIDS, 2012, 47 (12) :1221-1229